Deallus

Deallus

Healthcare and life sciences consulting

Overview

Deallus provides consulting services for the life sciences and healthcare sectors. It helps pharmaceutical, biotechnology, medical device, and healthcare companies with research-driven strategic support, including competitive intelligence, market analyses, pipeline and product strategy, and due diligence for mergers, partnerships, or investments. Its offerings translate scientific and market data into actionable insights through customized reports, dashboards, and advisory services. What sets Deallus apart is its focus on life sciences and health care, combining deep scientific understanding with intelligence and strategy work to deliver targeted, decision-ready analysis. The company aims to help clients make informed, faster decisions to maximize value in drug development, commercialization, and healthcare products.

About Deallus

Simplify's Rating
Why Deallus is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consulting

Biotechnology

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2012

Get referred to Deallus

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Deallus hired new U.S. specialists in March 2026 across forecasting and oncology.
  • GlobalData says Deallus strengthens its deepest healthcare insights bench and AI-enabled tools.
  • Life-sciences clients still need human judgment for competitive strategy, rare diseases, and launches.

What critics are saying

  • GlobalData integration can trigger talent flight; losing senior consultants destroys Deallus's moat in 2026.
  • Big Pharma increasingly buys cheaper data platforms, squeezing Deallus's premium consulting pricing.
  • If GlobalData cuts Deallus autonomy, the brand becomes a commoditized healthcare analytics appendix.

What makes Deallus unique

  • Deallus built 20 years of life-sciences competitive intelligence, especially oncology and vaccines.
  • Its consultants combine therapy-area expertise with market access, forecasting, and portfolio strategy.
  • GlobalData bought Deallus on 31 December 2024, adding proprietary data and AI.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Deallus is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →